InsidersTradesSigma
Track the 바이오솔루션 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오솔루션 has recorded 1 reports. Market capitalisation: €150.7bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 바이오솔루션. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 22,827 of 29,064 companies
31.8
score / 100
Value25
Quality39
FCF yld-1.4%
Earn yld0.2%
EV/EBITDA34.3x
ROE-2.5%
Gross mgn63%
Net mgn1.8%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 March 2026
关于 바이오솔루션
BioSolution 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于创新生物解决方案的开发。